Viewing Study NCT05603195


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-27 @ 1:40 AM
Study NCT ID: NCT05603195
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thrombotic disorders View